Sanghi Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:02 pm

Quick Insight

Sanghi Industries Ltd's current market dynamics present a mixed picture for investors. With a share price of 63.8 and a market capitalization of 1,648 Cr., the company's P/E ratio is not available, indicating a need for further evaluation. Despite a robust ROE of 46.1% and a P/BV ratio of 2.50x, its ROCE of 3.91% raises concerns about operational efficiency. The high level of borrowings at ₹2,506 Cr. and a low ICR of 0.46x suggest potential liquidity challenges. Investors should closely monitor the company's ability to manage debt and improve operational performance to mitigate risks and enhance shareholder value in the long term.

Competitors of Sanghi Industries Ltd

All Competitor Stocks of Sanghi Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 12:45 pm

Below is a detailed analysis of the quarterly data for Sanghi Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 245.00 Cr.. The value appears to be declining and may need further review. It has decreased from 335.00 Cr. (Mar 2025) to 245.00 Cr., marking a decrease of 90.00 Cr..
• For Expenses, as of Jun 2025, the value is 220.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 299.00 Cr. (Mar 2025) to 220.00 Cr., marking a decrease of 79.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 25.00 Cr., marking a decrease of 11.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Mar 2025) to 10.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 31.00 Cr..
• For Interest, as of Jun 2025, the value is 54.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 66.00 Cr. (Mar 2025) to 54.00 Cr., marking a decrease of 12.00 Cr..
• For Depreciation, as of Jun 2025, the value is 90.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 98.00 Cr. (Mar 2025) to 90.00 Cr., marking a decrease of 8.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -75.00 Cr.. The value appears strong and on an upward trend. It has increased from -117.00 Cr. (Mar 2025) to -75.00 Cr., marking an increase of 42.00 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -75.00 Cr.. The value appears strong and on an upward trend. It has increased from -117.00 Cr. (Mar 2025) to -75.00 Cr., marking an increase of 42.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -2.92. The value appears strong and on an upward trend. It has increased from -4.53 (Mar 2025) to -2.92, marking an increase of 1.61.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:13 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 11, 2025, 2:43 pm

Below is a detailed analysis of the balance sheet data for Sanghi Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 258.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 258.00 Cr..
• For Reserves, as of Mar 2025, the value is 354.00 Cr.. The value appears to be declining and may need further review. It has decreased from 852.00 Cr. (Mar 2024) to 354.00 Cr., marking a decrease of 498.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,506.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 2,084.00 Cr. (Mar 2024) to 2,506.00 Cr., marking an increase of 422.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 615.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 434.00 Cr. (Mar 2024) to 615.00 Cr., marking an increase of 181.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,733.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,628.00 Cr. (Mar 2024) to 3,733.00 Cr., marking an increase of 105.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 3,090.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,185.00 Cr. (Mar 2024) to 3,090.00 Cr., marking a decrease of 95.00 Cr..
• For CWIP, as of Mar 2025, the value is 149.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 149.00 Cr., marking an increase of 145.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 494.00 Cr.. The value appears strong and on an upward trend. It has increased from 439.00 Cr. (Mar 2024) to 494.00 Cr., marking an increase of 55.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,733.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,628.00 Cr. (Mar 2024) to 3,733.00 Cr., marking an increase of 105.00 Cr..

However, the Borrowings (2,506.00 Cr.) are higher than the Reserves (354.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Sanghi Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -19.29. This value is below the healthy minimum of 5. It has decreased from -17.37 (Mar 24) to -19.29, marking a decrease of 1.92.
• For Diluted EPS (Rs.), as of Mar 25, the value is -19.29. This value is below the healthy minimum of 5. It has decreased from -17.37 (Mar 24) to -19.29, marking a decrease of 1.92.
• For Cash EPS (Rs.), as of Mar 25, the value is -10.84. This value is below the healthy minimum of 3. It has increased from -13.23 (Mar 24) to -10.84, marking an increase of 2.39.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.71. It has decreased from 43.00 (Mar 24) to 23.71, marking a decrease of 19.29.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.71. It has decreased from 43.00 (Mar 24) to 23.71, marking a decrease of 19.29.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 37.50. It has increased from 31.79 (Mar 24) to 37.50, marking an increase of 5.71.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 4.09. This value is within the healthy range. It has increased from -2.92 (Mar 24) to 4.09, marking an increase of 7.01.
• For PBIT / Share (Rs.), as of Mar 25, the value is -4.36. This value is below the healthy minimum of 0. It has increased from -7.06 (Mar 24) to -4.36, marking an increase of 2.70.
• For PBT / Share (Rs.), as of Mar 25, the value is -17.87. This value is below the healthy minimum of 0. It has decreased from -17.36 (Mar 24) to -17.87, marking a decrease of 0.51.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -19.29. This value is below the healthy minimum of 2. It has decreased from -17.37 (Mar 24) to -19.29, marking a decrease of 1.92.
• For PBDIT Margin (%), as of Mar 25, the value is 10.90. This value is within the healthy range. It has increased from -9.18 (Mar 24) to 10.90, marking an increase of 20.08.
• For PBIT Margin (%), as of Mar 25, the value is -11.62. This value is below the healthy minimum of 10. It has increased from -22.21 (Mar 24) to -11.62, marking an increase of 10.59.
• For PBT Margin (%), as of Mar 25, the value is -47.65. This value is below the healthy minimum of 10. It has increased from -54.61 (Mar 24) to -47.65, marking an increase of 6.96.
• For Net Profit Margin (%), as of Mar 25, the value is -51.44. This value is below the healthy minimum of 5. It has increased from -54.64 (Mar 24) to -51.44, marking an increase of 3.20.
• For Return on Networth / Equity (%), as of Mar 25, the value is -81.37. This value is below the healthy minimum of 15. It has decreased from -40.40 (Mar 24) to -81.37, marking a decrease of 40.97.
• For Return on Capital Employeed (%), as of Mar 25, the value is -3.47. This value is below the healthy minimum of 10. It has increased from -5.58 (Mar 24) to -3.47, marking an increase of 2.11.
• For Return On Assets (%), as of Mar 25, the value is -13.34. This value is below the healthy minimum of 5. It has decreased from -12.36 (Mar 24) to -13.34, marking a decrease of 0.98.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 4.06. This value exceeds the healthy maximum of 1. It has increased from 1.87 (Mar 24) to 4.06, marking an increase of 2.19.
• For Total Debt / Equity (X), as of Mar 25, the value is 4.06. This value exceeds the healthy maximum of 1. It has increased from 1.87 (Mar 24) to 4.06, marking an increase of 2.19.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.26. It has increased from 0.22 (Mar 24) to 0.26, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1.5. It has decreased from 1.07 (Mar 24) to 0.97, marking a decrease of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.69 (Mar 24) to 0.33, marking a decrease of 0.36.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 4. It has decreased from 2.06 (Mar 24) to 0.45, marking a decrease of 1.61.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 3. It has increased from -0.26 (Mar 24) to 0.46, marking an increase of 0.72.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.65. This value is below the healthy minimum of 3. It has decreased from -0.64 (Mar 24) to -0.65, marking a decrease of 0.01.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,996.05. It has decreased from 4,226.92 (Mar 24) to 3,996.05, marking a decrease of 230.87.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.13. This value exceeds the healthy maximum of 3. It has decreased from 5.15 (Mar 24) to 4.13, marking a decrease of 1.02.
• For EV / EBITDA (X), as of Mar 25, the value is 37.81. This value exceeds the healthy maximum of 15. It has increased from -56.03 (Mar 24) to 37.81, marking an increase of 93.84.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 2.85 (Mar 24) to 1.58, marking a decrease of 1.27.
• For Price / BV (X), as of Mar 25, the value is 2.50. This value is within the healthy range. It has increased from 2.10 (Mar 24) to 2.50, marking an increase of 0.40.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 2.85 (Mar 24) to 1.58, marking a decrease of 1.27.
• For EarningsYield, as of Mar 25, the value is -0.32. This value is below the healthy minimum of 5. It has decreased from -0.19 (Mar 24) to -0.32, marking a decrease of 0.13.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness